We could not find any results for:
Make sure your spelling is correct or try broadening your search.
The current ANRO market cap is 346.18M. The company's latest EPS is USD -1.3550 and P/E is -9.54.
Quarter End | Dec 2023 | |
---|---|---|
USD (US$) | USD (US$) | |
Total Revenue | 0 | |
Operating Income | -11.77M | |
Net Income | -11.22M |
Year End 31 December 2023 | 2022 | 2023 |
---|---|---|
USD (US$) | USD (US$) | |
Total Revenue | 0 | 0 |
Operating Income | -29.19M | -37.81M |
Net Income | -27.71M | -36.31M |
Quarter End | Dec 2023 | |
---|---|---|
USD (US$) | USD (US$) | |
Total Assets | 86.63M | |
Total Liabilities | 16.82M | |
Total Equity | -71.67M |
Year End 31 December 2023 | 2022 | 2023 |
---|---|---|
USD (US$) | USD (US$) | |
Total Assets | 50.85M | 86.63M |
Total Liabilities | 17.03M | 16.82M |
Total Equity | -38.41M | -71.67M |
Market Cap | 346.18M |
Price to Earnings Ratio | -9.54 |
Price to Sales Ratio | 0 |
Price to Cash Ratio | 4.19 |
Price to Book Ratio | 4.96 |
Dividend Yield | - |
Shares Outstanding | 26.79M |
Average Volume (1 week) | 138.78k |
Average Volume (1 Month) | 96.81k |
52 Week Change | -41.27% |
52 Week High | 24.00 |
52 Week Low | 11.68 |
Spread (Intraday) | 3.08 (19.64%) |
Company Name | Alto Neuroscience Inc |
Address |
corporation trust center wilmington, delaware 19801 |
Website | https://www.altoneuroscience.com |
Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions